List of Tables
Table 1. Global Gabapentin Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Gabapentin Market Value by Therapeutic Indication (US$ Million), 2025 vs 2032
Table 3. Global Gabapentin Market Value by Product Type (US$ Million), 2025 vs 2032
Table 4. Global Gabapentin Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Gabapentin Market Competitive Situation by Manufacturers in 2025
Table 6. Global Gabapentin Sales (M Units) of Key Manufacturers (2021–2026)
Table 7. Global Gabapentin Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Gabapentin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Gabapentin Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Gabapentin Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Gabapentin, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Gabapentin, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Gabapentin, Product Types and Applications
Table 14. Global Key Manufacturers of Gabapentin, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Gabapentin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Gabapentin Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Gabapentin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Gabapentin Sales by Region (M Units), 2021–2026
Table 20. Global Gabapentin Sales Market Share by Region (2021–2026)
Table 21. Global Gabapentin Sales by Region (M Units), 2027–2032
Table 22. Global Gabapentin Sales Market Share by Region (2027–2032)
Table 23. Global Gabapentin Revenue by Region (US$ Million), 2021–2026
Table 24. Global Gabapentin Revenue Market Share by Region (2021–2026)
Table 25. Global Gabapentin Revenue by Region (US$ Million), 2027–2032
Table 26. Global Gabapentin Revenue Market Share by Region (2027–2032)
Table 27. North America Gabapentin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Gabapentin Sales by Country (M Units), 2021–2026
Table 29. North America Gabapentin Sales by Country (M Units), 2027–2032
Table 30. North America Gabapentin Revenue by Country (US$ Million), 2021–2026
Table 31. North America Gabapentin Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Gabapentin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Gabapentin Sales by Country (M Units), 2021–2026
Table 34. Europe Gabapentin Sales by Country (M Units), 2027–2032
Table 35. Europe Gabapentin Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Gabapentin Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Gabapentin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Gabapentin Sales by Region (M Units), 2021–2026
Table 39. Asia Pacific Gabapentin Sales by Region (M Units), 2027–2032
Table 40. Asia Pacific Gabapentin Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Gabapentin Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Gabapentin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Gabapentin Sales by Country (M Units), 2021–2026
Table 44. Latin America Gabapentin Sales by Country (M Units), 2027–2032
Table 45. Latin America Gabapentin Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Gabapentin Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Gabapentin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Gabapentin Sales by Country (M Units), 2021–2026
Table 49. Middle East and Africa Gabapentin Sales by Country (M Units), 2027–2032
Table 50. Middle East and Africa Gabapentin Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Gabapentin Revenue by Country (US$ Million), 2027–2032
Table 52. Global Gabapentin Sales (M Units) by Type (2021–2026)
Table 53. Global Gabapentin Sales (M Units) by Type (2027–2032)
Table 54. Global Gabapentin Sales Market Share by Type (2021–2026)
Table 55. Global Gabapentin Sales Market Share by Type (2027–2032)
Table 56. Global Gabapentin Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Gabapentin Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Gabapentin Revenue Market Share by Type (2021–2026)
Table 59. Global Gabapentin Revenue Market Share by Type (2027–2032)
Table 60. Global Gabapentin Price (US$/Unit) by Type (2021–2026)
Table 61. Global Gabapentin Price (US$/Unit) by Type (2027–2032)
Table 62. Global Gabapentin Sales (M Units) by Application (2021–2026)
Table 63. Global Gabapentin Sales (M Units) by Application (2027–2032)
Table 64. Global Gabapentin Sales Market Share by Application (2021–2026)
Table 65. Global Gabapentin Sales Market Share by Application (2027–2032)
Table 66. Global Gabapentin Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Gabapentin Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Gabapentin Revenue Market Share by Application (2021–2026)
Table 69. Global Gabapentin Revenue Market Share by Application (2027–2032)
Table 70. Global Gabapentin Price (US$/Unit) by Application (2021–2026)
Table 71. Global Gabapentin Price (US$/Unit) by Application (2027–2032)
Table 72. Pfizer Company Information
Table 73. Pfizer Description and Business Overview
Table 74. Pfizer Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Pfizer Gabapentin Product
Table 76. Pfizer Recent Developments/Updates
Table 77. Depomed Company Information
Table 78. Depomed Description and Business Overview
Table 79. Depomed Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Depomed Gabapentin Product
Table 81. Depomed Recent Developments/Updates
Table 82. TEVA Company Information
Table 83. TEVA Description and Business Overview
Table 84. TEVA Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. TEVA Gabapentin Product
Table 86. TEVA Recent Developments/Updates
Table 87. Viatris Company Information
Table 88. Viatris Description and Business Overview
Table 89. Viatris Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Viatris Gabapentin Product
Table 91. Viatris Recent Developments/Updates
Table 92. Alvogen Company Information
Table 93. Alvogen Description and Business Overview
Table 94. Alvogen Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Alvogen Gabapentin Product
Table 96. Alvogen Recent Developments/Updates
Table 97. Novartis Company Information
Table 98. Novartis Description and Business Overview
Table 99. Novartis Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Novartis Gabapentin Product
Table 101. Novartis Recent Developments/Updates
Table 102. Apotex Company Information
Table 103. Apotex Description and Business Overview
Table 104. Apotex Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Apotex Gabapentin Product
Table 106. Apotex Recent Developments/Updates
Table 107. Sun Pharmaceutical Company Information
Table 108. Sun Pharmaceutical Description and Business Overview
Table 109. Sun Pharmaceutical Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. Sun Pharmaceutical Gabapentin Product
Table 111. Sun Pharmaceutical Recent Developments/Updates
Table 112. Aurobindo Pharma Company Information
Table 113. Aurobindo Pharma Description and Business Overview
Table 114. Aurobindo Pharma Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Aurobindo Pharma Gabapentin Product
Table 116. Aurobindo Pharma Recent Developments/Updates
Table 117. Intas Company Information
Table 118. Intas Description and Business Overview
Table 119. Intas Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Intas Gabapentin Product
Table 121. Intas Recent Developments/Updates
Table 122. Amneal Company Information
Table 123. Amneal Description and Business Overview
Table 124. Amneal Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Amneal Gabapentin Product
Table 126. Amneal Recent Developments/Updates
Table 127. Marksans Pharma Company Information
Table 128. Marksans Pharma Description and Business Overview
Table 129. Marksans Pharma Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Marksans Pharma Gabapentin Product
Table 131. Marksans Pharma Recent Developments/Updates
Table 132. Glenmark Company Information
Table 133. Glenmark Description and Business Overview
Table 134. Glenmark Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. Glenmark Gabapentin Product
Table 136. Glenmark Recent Developments/Updates
Table 137. Alkem Company Information
Table 138. Alkem Description and Business Overview
Table 139. Alkem Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 140. Alkem Gabapentin Product
Table 141. Alkem Recent Developments/Updates
Table 142. Jiangsu Enhua Company Information
Table 143. Jiangsu Enhua Description and Business Overview
Table 144. Jiangsu Enhua Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 145. Jiangsu Enhua Gabapentin Product
Table 146. Jiangsu Enhua Recent Developments/Updates
Table 147. Jiangsu Hengrui Company Information
Table 148. Jiangsu Hengrui Description and Business Overview
Table 149. Jiangsu Hengrui Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 150. Jiangsu Hengrui Gabapentin Product
Table 151. Jiangsu Hengrui Recent Developments/Updates
Table 152. Sailike Company Information
Table 153. Sailike Description and Business Overview
Table 154. Sailike Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 155. Sailike Gabapentin Product
Table 156. Sailike Recent Developments/Updates
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Gabapentin Distributors List
Table 160. Gabapentin Customers List
Table 161. Gabapentin Market Trends
Table 162. Gabapentin Market Drivers
Table 163. Gabapentin Market Challenges
Table 164. Gabapentin Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 168. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gabapentin
Figure 2. Global Gabapentin Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Gabapentin Market Share by Type: 2025 & 2032
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Injection Product Picture
Figure 7. Global Gabapentin Market Value by Therapeutic Indication (US$ Million), 2021–2032
Figure 8. Global Gabapentin Market Share by Therapeutic Indication: 2025 vs 2032
Figure 9. Epilepsy Product Picture
Figure 10. Neuropathic Pain Product Picture
Figure 11. Restless Legs Syndrome Product Picture
Figure 12. Others Product Picture
Figure 13. Global Gabapentin Market Value by Product Type (US$ Million), 2021–2032
Figure 14. Global Gabapentin Market Share by Product Type: 2025 vs 2032
Figure 15. Branded Gabapentin Product Picture
Figure 16. Generic Gabapentin Product Picture
Figure 17. Global Gabapentin Market Value by Application (US$ Million), 2021–2032
Figure 18. Global Gabapentin Market Share by Application: 2025 & 2032
Figure 19. Hospital
Figure 20. Retail Pharmacy
Figure 21. Global Gabapentin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Gabapentin Market Size (US$ Million), 2021–2032
Figure 23. Global Gabapentin Sales (M Units), 2021–2032
Figure 24. Global Gabapentin Average Price (US$/Unit), 2021–2032
Figure 25. Gabapentin Report Years Considered
Figure 26. Gabapentin Sales Share by Manufacturers in 2025
Figure 27. Global Gabapentin Revenue Share by Manufacturers in 2025
Figure 28. Top 5 and Top 10 Global Gabapentin Players: Market Share by Revenue in Gabapentin in 2025
Figure 29. Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 30. Global Gabapentin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 31. North America Gabapentin Sales Market Share by Country (2021–2032)
Figure 32. North America Gabapentin Revenue Market Share by Country (2021–2032)
Figure 33. U.S. Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Canada Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Europe Gabapentin Sales Market Share by Country (2021–2032)
Figure 36. Europe Gabapentin Revenue Market Share by Country (2021–2032)
Figure 37. Germany Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. France Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. U.K. Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Italy Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Russia Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Asia Pacific Gabapentin Sales Market Share by Region (2021–2032)
Figure 43. Asia Pacific Gabapentin Revenue Market Share by Region (2021–2032)
Figure 44. China Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Japan Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. South Korea Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. India Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Australia Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Taiwan Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Indonesia Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Thailand Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Malaysia Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Philippines Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Latin America Gabapentin Sales Market Share by Country (2021–2032)
Figure 55. Latin America Gabapentin Revenue Market Share by Country (2021–2032)
Figure 56. Mexico Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Brazil Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Argentina Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Middle East and Africa Gabapentin Sales Market Share by Country (2021–2032)
Figure 60. Middle East and Africa Gabapentin Revenue Market Share by Country (2021–2032)
Figure 61. Turkey Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Saudi Arabia Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. U.A.E Gabapentin Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Global Sales Market Share of Gabapentin by Type (2021–2032)
Figure 65. Global Revenue Market Share of Gabapentin by Type (2021–2032)
Figure 66. Global Gabapentin Price (US$/Unit) by Type (2021–2032)
Figure 67. Global Sales Market Share of Gabapentin by Application (2021–2032)
Figure 68. Global Revenue Market Share of Gabapentin by Application (2021–2032)
Figure 69. Global Gabapentin Price (US$/Unit) by Application (2021–2032)
Figure 70. Gabapentin Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
